Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
40.45
+3.42 (9.24%)
At close: Feb 10, 2026, 4:00 PM EST
39.91
-0.54 (-1.33%)
Pre-market: Feb 11, 2026, 4:58 AM EST
Veradermics Market Cap
Veradermics has a market cap or net worth of $1.51 billion as of February 11, 2026.
Market Cap
1.51B
Enterprise Value
1.50B
1-Year Change
n/a
Ranking
Category
Stock Price
40.45
Market Cap Chart
Since the IPO on February 4, 2026, Veradermics's market cap has increased from $1.32B to $1.51B, an increase of 14.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.51B | 9.24% |
| Feb 9, 2026 | 1.38B | -3.77% |
| Feb 6, 2026 | 1.44B | 3.55% |
| Feb 5, 2026 | 1.39B | 4.78% |
| Feb 4, 2026 | 1.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intellia Therapeutics | 1.45B |
| AtaiBeckley | 1.43B |
| Trevi Therapeutics | 1.43B |
| Novavax | 1.41B |
| Upstream Bio | 1.41B |
| AnaptysBio | 1.38B |
| Immatics | 1.38B |
| Fortrea Holdings | 1.38B |